Zacks Investment Research downgraded shares of Victrex (OTCMKTS:VTXPF) from a buy rating to a hold rating in a report released on Sunday, January 21st.
According to Zacks, “Victrex Plc engages in the manufacture and marketing of polymers. The company offers products under the Victrex, Aptiv, Vicote and Victrex Pipes brands. It operates through the Victrex Polymer Solutions and Invibio Biomaterial Solutions segments. Victrex Polymer Solutions segment focuses on the automotive, aerospace, electronics and energy markets. Invibio Biomaterial Solutions provides solutions for medical device manufacturers. Victrex Plc is headquartered in Thornton Cleveleys, United Kingdom. “
Victrex (OTCMKTS VTXPF) traded down $0.13 during trading hours on Friday, hitting $34.61. The company had a trading volume of 200 shares, compared to its average volume of 667. Victrex has a 12 month low of $22.80 and a 12 month high of $37.58.
COPYRIGHT VIOLATION WARNING: This piece of content was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece of content on another domain, it was stolen and republished in violation of U.S. & international trademark and copyright legislation. The original version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/02/14/victrex-vtxpf-stock-rating-lowered-by-zacks-investment-research.html.
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. It operates through two segments, Victrex Polymer Solutions and Invibio Biomaterial Solutions. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, dental, trauma, knee, cardiovascular, and orthopedic applications.
Get a free copy of the Zacks research report on Victrex (VTXPF)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.